Milestone Scientific Inc(MLSS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.05 | Insider Own | 16.43% | Shs Outstand | 88.8M | Perf Week | -10.46% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 12.5% | Insider Trans | - | Shs Float | 75.8M | Perf Month | -21.76% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.01 | Inst Own | 5.19% | Short Float | 0.12% | Perf Quarter | 8.77% |
| Income | -0.00B | P/S | 3.53 | EPS this Y | 42.86% | Inst Trans | 0.41% | Short Ratio | 0.71 | Perf Half Y | 30.18% |
| Sales | 0.01B | P/B | 9.39 | EPS next 5Y | 34.14% | ROA | -50.54% | Short Interest | 0.09M | Perf YTD | 34.47% |
| Book/sh | 0.04 | P/C | 16.07 | EPS past 3/5Y | 17.32% 9.75% | ROE | -121.67% | 52W High | -38.82% ($0.60) | Perf Year | -18.23% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | 0.63% 10.54% | ROIC | -104.89% | 52W Low | 68.32% ($0.22) | Perf 3Y | -60.26% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 43.78% | Gross Margin | 69.4% | Volatility(W/M) | 9.44% 8.89% | Perf 5Y | -82.09% |
| Dividend TTM | - | EV/Sales | 3.38 | Sales Y/Y TTM | 3.72% | Oper. Margin | -43.56% | ATR (14) | 0.03 | Perf 10Y | -81.46% |
| Dividend Ex-Date | - | Quick Ratio | 1.14 | EPS Q/Q | 37.02% | Profit Margin | -43.98% | RSI (14) | 35.8 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.85 | Sales Q/Q | 22.28% | SMA20 | -9.52% ($0.41) | Beta | 1.1 | Target Price | $1.25 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/8/14 | SMA50 | -17.46% ($0.45) | Rel Volume | 0.99 | Prev Close | $0.36 |
| Employees | 15 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | - 5.22% | SMA200 | 4.53% ($0.35) | Avg Volume(3M) | 0.13M | Price | $0.37 |
| IPO | 1995/11/3 | Option/Short | Yes/Yes | Trades | 226 | Volume | 127,534 | Change | 1.41% |
Milestone Scientific () is a medical device company that develops and sells computer-controlled injection technology. Its flagship products, The Wand (single-tooth anesthesia) and CompuFlo and CompuFlo Epidural, monitor injection pressure in real time with the goal of reducing pain and improving the accuracy of drug delivery. Its primary market is dentistry, and the company is expanding into the medical epidural injection space.
Over the past 1 year, roughly in the middle
38% below its 1-year high.
Traded about as much as usual That is 99% of its average volume.
MLSS has a sound balance sheet but weak earning power
Of every $100 in sales, $43.56 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +42.9% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $353. Peers typically go for $270.
Tap to view numbers
Results came in about as expected
Generally in line with estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -82.1%. The S&P 500 did +79% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 5.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VTI Vanguard Morningstar Total Stock Market ETF <0.01% 
VXF Vanguard Extended Market Index ETF <0.01% It ranks #43 of 51 in the industry
Based on market cap of $33M.
POCI#41 Precision Optics Corp Inc $49M PER - 
HBIO#42 Harvard Bioscience Inc $39M PER - MLSS#43 Milestone Scientific Inc $33M PER - 
NEPH#44 Nephros Inc $33M PER 19.3 
RVP#45 Retractable Technologies Inc $21M PER - 
FAQ
What kind of company is MLSS?
MLSS belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of MLSS?
The market cap of MLSS is approximately $33M, ranking 5,101 within its sector.
What is the 52-week high and low for MLSS?
MLSS has recorded a 52-week high of $0.60 and a low of $0.22.
